IMMUTEP Ltd
IMMP · PRRUF · Pharmaceutical Preparations
Latest available SEC filing: 3 ·
Latest disclosures
-
Boyce Elisabeth Amanda: Form 3
Insider disclosure · Filed · Report period 18 Mar 2026
-
Form 3
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Latest financial period: Q2 2025
Financial facts · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
Company details and SEC sources
CIK 0001506184 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- IMMP on Nasdaq, PRRUF on OTC
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- Level 32, Suite 32.07 Australia Square, 264 George Street, Sydney,, Australia, NSW 2000
- Incorporated in
- Australia
- Fiscal year end
- 30 June
- Former names on EDGAR
- Prima BioMed Ltd (to 01 Dec 2017)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields